Form 4: Director Tariq Musa Executes Guardant Health Stock Trade

Director Tariq Musa reported the vesting of restricted stock units and a subsequent sale of Guardant Health common stock.

Summary

• Director Tariq Musa acquired 250 shares of common stock through the vesting of restricted stock units on June 15, 2026.
• On June 16, 2026, the director sold 116 shares of common stock at a price of $130.19 per share.
• Following these transactions, the director holds 8,796 shares of Guardant Health common stock.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative action related to equity compensation and a pre-planned trading arrangement.

Positives

• The transaction reflects the standard vesting schedule of equity compensation for company leadership.

Negatives

• The director reduced their total beneficial ownership by 116 shares.

Risks

• None identified in this filing.

Future Outlook

Not applicable; this is a routine disclosure of insider equity transactions.

Industry Context

StockSavvy.ai notes that routine insider selling under 10b5-1 plans is common practice for corporate directors and does not necessarily signal a change in management sentiment regarding the company's long-term prospects.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a standard industry practice to ensure compliance with insider trading regulations.

Stakeholder Impact

• Minimal impact on shareholders as the transaction volume is small relative to total outstanding shares.

Next Steps

• No future actions mentioned.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Trading, Director, Equity Compensation